IVIG and under Burn Unit Care Yield Favorable Outcomes in Pediatric Patients with Toxic Epidermal Necrolysis: A Case Report and Literature Review

IVIG and under Burn Unit Care Yield Favorable Outcomes in Pediatric Patients with Toxic Epidermal Necrolysis: A Case Report and Literature Review

Body reactions to drugs can manifest as Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). TEN is the most severe form of cutaneous reactions with an incidence rate of 1-2 per million cases per year. Despite TEN being a critical and life-threatening condition, there is little to no...

Full description

Bibliographic Details
Main Authors:	Tareq Z. Alzughayyar, Wasim Noureddin Ibrahim Hamad, Eman A. S. Abuqweider, Bilal Nabeel Mohammad Alqam, Sadi A. Abukhalaf, Rami A. Misk, Fawzy M. Abunejma, Jihad Samer Zalloum, Mohanad Saleh, Ali A. Abumunshar, Yousef I. M. Zatari
Format:	Article
Language:	English
Published:	Hindawi Limited 2020-01-01
Series:	Case Reports in Dermatological Medicine
Online Access:	http://dx.doi.org/10.1155/2020/6274053

Similar Items

Systemic Lupus Erythematosus with Multiple Autoimmune Disease Presented with Extensive Peripheral Gangrene
by: Tareq Z. Alzughayyar, et al.
Published: (2020-01-01)

Familial Mediterranean Fever Complicated by a Triad of Adrenal Crisis: Amyloid Goiter and Cardiac Amyloidosis
by: Sadi A. Abukhalaf, et al.
Published: (2020-01-01)

Treatment of scleromyxedema with IVIg
by: Moser David W, et al.
Published: (2012-07-01)

H-type anorectal malformation associated with H-type tracheoesophageal fistula
by: Sadi A. Abukhalaf, et al.
Published: (2019-05-01)

Methylprednisolone Pulse Therapy or Additional IVIG for Patients with IVIG-Resistant Kawasaki Disease
by: Zhouping Wang, et al.
Published: (2020-01-01)

A comparative study of IVIG versus IVIG with IV methylprednisolone in guillain–barre syndrome
by: Rahi Kiran Bhattiprolu, et al.
Published: (2020-01-01)

Eczematous reaction to IVIG for the treatment of dermatomyositis
by: J. Berk-Krauss, et al.
Published: (2018-09-01)

Comparing the Outcomes of IVIg with Combination of IVIg and Methylprednisolone in Children with Acute Idiopathic Thrombocytopenia; a Bayesian Logistic Approach
by: Seyed Kamal Eshagh-Hoseini, et al.
Published: (2016-07-01)

IVIG regulates the survival of human but not mouse neutrophils
by: Christoph Schneider, et al.
Published: (2017-05-01)

Comparing Plasmapheresis plus IVIg with Plasmapheresis plus IVIg plus Rituximab on the Management of Suspicious Antibody-Mediated Acute Rejection in Kidney Transplant Recipients
by: F Ahmadi, et al.
Published: (2019-07-01)

TOXIC EPIDERMAL NECROLYSIS (LYELL’S SYNDROME)
by: E. N. Kudelka, et al.
Published: (2018-01-01)

Appropriate indicated use for IVIG in neonatal infections
by: Ying Wang, et al.

IVIG Effects on Erythrocyte Sedimentation Rate in Children
by: Farhad Salehzadeh, et al.
Published: (2014-01-01)

Tregitope Peptides: The Active Pharmaceutical Ingredient of IVIG?
by: Anne S. De Groot, et al.
Published: (2013-01-01)

Toxic Epidermal Necrolysis
by: Syed Naveed Ali Shah, et al.
Published: (2020-11-01)

Epidermal necrolysis (Stevens–Johnson syndrome and toxic epidermal necrolysis): Historical considerations
by: Jean-Claude Roujeau
Published: (2013-12-01)

Appendicitis-Like Picture Induced by Foreign Body in a 2-Year-Old Boy
by: Sadi A. Abukhalaf, et al.
Published: (2020-01-01)

Investigation of the immunomodulatory properties of intravenous immunoglobulin G (IVIg)
by: Pain, Elisabeth
Published: (2002)

IgG Glyco-Engineering to Improve IVIg Potency
by: Christine W. Bruggeman, et al.
Published: (2018-10-01)

The effects of hair regrowth with intravenous immunoglobulin (IVIG) therapy. Two case reports
by: Joseph A. Cahill, et al.
Published: (2017-07-01)

Review of Toxic Epidermal Necrolysis
by: Victoria Harris, et al.
Published: (2016-12-01)

Skin Detachment and Regrowth in Toxic Epidermal Necrolysis
by: Laurence Feldmeyer, et al.
Published: (2010-04-01)

EFFECTS OF IVIG TREATMENT UPON LOCAL AND GENERAL IMMUNITY STATE IN THE PATIENTS WITH ACUTE EPIGLOTTITIS
by: A. V. Savchenko, et al.
Published: (2014-07-01)

Sensor integration for robotic task planning and position determination
by: Zatari, A.
Published: (2005)

IVIG induced Hemolytic anemia – A report of two cases
by: Putun Patel, et al.
Published: (2017-01-01)

Persistent immune activation in CVID and the role of IVIg in its suppression
by: Dominic ePaquin-Proulx, et al.
Published: (2014-12-01)

IVIG Associated Aseptic Meningitis in a Renal Transplant Patient
by: Tamara Wanigasekera, et al.
Published: (2017-01-01)

Transient lymphadenopathy during intravenous immunoglobulin (IVIg) in a patient with pemphigus vulgaris
by: Delila Pouldar Foulad, et al.
Published: (2021-09-01)

Economic impact of infections among patients with primary immunodeficiency disease receiving IVIG therapy
by: Menzin J, et al.
Published: (2014-06-01)

Perforated Sigmoid Diverticulitis in the Presence of Toxic Epidermal Necrolysis
by: P. Heye, et al.
Published: (2014-02-01)

Intravenous Immunoglobulin in the Treatment of Vancomycin-Induced Toxic Epidermal Necrolysis
by: Mohamed A. El-Naggari, et al.
Published: (2013-02-01)

Toxic epidermal necrolysis in hemodialysis patient
by: Uday Venkat Mateti, et al.
Published: (2015-01-01)

Rapidly Developing Toxic Epidermal Necrolysis
by: Viktoria Oline Barrios Poulsen, et al.
Published: (2013-01-01)

Early Manifestations of Toxic Epidermal Necrolysis
by: James Chapman, et al.
Published: (2017-10-01)

Ophthalmological perspectives of toxic epidermal necrolysis
by: Gayatree Mohanty, et al.
Published: (2019-01-01)

Simvastatin-induced Toxic Epidermal Necrolysis
by: Emmanouil Petrou, et al.
Published: (2014-01-01)

Clinical Case of Toxic Epidermal Necrolysis
by: Radenkova-Saeva J., et al.
Published: (2017-05-01)

Individualizing Therapy in CIDP: A Mini-Review Comparing the Pharmacokinetics of Ig With SCIg and IVIg
by: Said R. Beydoun, et al.
Published: (2021-03-01)

Kawasaki disease and acute haemolytic anaemia after two IVIG infusions
by: Albena Telcharova-Mihaylovska, et al.
Published: (2016-05-01)

IVIG-Associated Maternal Pancytopenia during Treatment for Neonatal Alloimmune Thrombocytopenia
by: Alyssa Herrmann, et al.
Published: (2017-07-01)

Cannot write session to /tmp/vufind_sessions/sess_jj81a00u9ff2kqfdl03mt0c0st